Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties
暂无分享,去创建一个
S. Mandel | M. Youdim | T. Amit | O. Weinreb
[1] T. Cheng. Green tea does not inhibit iron absorption. , 2009, International journal of cardiology.
[2] E. Zenteno,et al. Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats , 2009, Neuroscience Research.
[3] Jae Woong Lee,et al. (−)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency , 2009, Brain Research.
[4] Khadija Iqbal,et al. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. , 2008, Current medicinal chemistry.
[5] O. Shido,et al. Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. , 2008, The Journal of nutritional biochemistry.
[6] Jen-kun Lin,et al. Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity , 2008, Journal of neuroscience research.
[7] M. Youdim,et al. The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate. , 2008, Archives of biochemistry and biophysics.
[8] E. Kua,et al. Tea consumption and cognitive impairment and decline in older Chinese adults. , 2008, The American journal of clinical nutrition.
[9] H. Hou,et al. Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice , 2008, Brain Research.
[10] Anup A. Kale,et al. Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (‐)epigallocatechin‐3‐gallate from green tea extract: a human study , 2008, Phytotherapy research : PTR.
[11] J. Spencer. Flavonoids: modulators of brain function? , 2008, British Journal of Nutrition.
[12] G. Rotilio,et al. Benefits from Dietary Polyphenols for Brain Aging and Alzheimer’s Disease , 2008, Neurochemical Research.
[13] P. Kalaiselvi,et al. Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (−)-epigallocatechin-3-gallate , 2008, International Journal of Developmental Neuroscience.
[14] Jian-Min Yuan,et al. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. , 2007, American journal of epidemiology.
[15] J. Spencer. The interactions of flavonoids within neuronal signalling pathways , 2007, Genes & Nutrition.
[16] M. Youdim,et al. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. , 2007, Free radical biology & medicine.
[17] C. Rice-Evans,et al. (‐)Epicatechin stimulates ERK‐dependent cyclic AMP response element activity and up‐regulates GluR2 in cortical neurons , 2007, Journal of neurochemistry.
[18] R. Ratan,et al. Hypoxia Inducible Factor Prolyl 4-Hydroxylase Enzymes: Center Stage in the Battle Against Hypoxia, Metabolic Compromise and Oxidative Stress , 2007, Neurochemical Research.
[19] R. Tanzi,et al. The 5′-untranslated region of Parkinson's disease α-synuclein messengerRNA contains a predicted iron responsive element , 2007, Molecular Psychiatry.
[20] S. Mandel,et al. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate promotes the rapid protein kinase C‐ and proteasome‐mediated degradation of Bad: implications for neuroprotection , 2007, Journal of neurochemistry.
[21] T. Tsai,et al. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. , 2007, Journal of agricultural and food chemistry.
[22] I. Grundke‐Iqbal,et al. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration , 2007, The European journal of neuroscience.
[23] W. Le,et al. Neuroprotective Effects of (-)-Epigallocatechin-3-gallate in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis , 2006, Neurochemical Research.
[24] B. Sutherland,et al. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. , 2006, The Journal of nutritional biochemistry.
[25] Xudong Tang,et al. Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1α protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells , 2006, Molecular Cancer Therapeutics.
[26] Reyes Artacho,et al. Beneficial Effects of Green Tea—A Review , 2006, Journal of the American College of Nutrition.
[27] S. Mandel,et al. Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease , 2006, Journal of neurochemistry.
[28] Young Joo Lee,et al. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice , 2006, Neuroscience Letters.
[29] H. S. Scheuller,et al. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. , 2006, Journal of agricultural and food chemistry.
[30] R. Nagatomi,et al. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. , 2006, The American journal of clinical nutrition.
[31] J. LaManna,et al. Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition , 2005, Journal of Biological Chemistry.
[32] Francis C. Lau,et al. The beneficial effects of fruit polyphenols on brain aging , 2005, Neurobiology of Aging.
[33] R. Wenger,et al. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors. , 2005, Cancer research.
[34] David Morgan,et al. Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice , 2005, The Journal of Neuroscience.
[35] Rusha Thomas,et al. Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells , 2005 .
[36] S. Mandel,et al. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth , 2005, Journal of neurochemistry.
[37] S. Mandel,et al. Multifunctional Activities of Green Tea Catechins in Neuroprotection , 2005, Neurosignals.
[38] T. Gasiewicz,et al. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. , 2005, Biochemistry.
[39] K. Pantopoulos,et al. The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL. , 2005, Biochimica et biophysica acta.
[40] D. Jackson,et al. Neuroprotective effects of (−)‐epigallocatechin gallate after hypoxia‐ischemia‐induced brain damage: novel mechanisms of action , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] D. Ferreira,et al. Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. , 2004, Journal of natural products.
[42] J. Kwak,et al. Phospholipase C, protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and redox state are involved in epigallocatechin gallate-induced phospholipase D activation in human astroglioma cells. , 2004, European journal of biochemistry.
[43] S. Mandel,et al. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. , 2004, The Journal of nutritional biochemistry.
[44] Myriam Bernaudin,et al. HIF1 and oxygen sensing in the brain , 2004, Nature Reviews Neuroscience.
[45] C. Rice-Evans,et al. Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.
[46] S. Mandel,et al. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases , 2004, Journal of neurochemistry.
[47] J. Jeong,et al. Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine. , 2004, Toxicology.
[48] H. Jung,et al. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. , 2003, Brain research. Molecular brain research.
[49] Ji Hyun Han,et al. Dual mechanisms of green tea extract‐induced cell survival in human epidermal keratinocytes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] A. Takashima,et al. Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.
[51] D. Berg,et al. 14-3-3 proteins in the nervous system , 2003, Nature Reviews Neuroscience.
[52] S. Mandel,et al. Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin , 2003, Annals of the New York Academy of Sciences.
[53] Xiaofeng Meng,et al. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[54] S. Mandel,et al. cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] S. Mandel,et al. Neuroprotection and neurorescue against Aβ toxicity and PKC‐dependent release of non‐amyloidogenic soluble precursor protein by green tea polyphenol (‐)‐epigallocatechin‐3‐gallate , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] C. Rice-Evans,et al. Interaction between flavonoids and the blood–brain barrier: in vitro studies , 2003, Journal of neurochemistry.
[57] Jen-kun Lin,et al. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. , 2003, Journal of agricultural and food chemistry.
[58] C. Pike,et al. Estrogen activates protein kinase C in neurons: role in neuroprotection , 2003, Journal of neurochemistry.
[59] S. Tsunenari,et al. Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidation--a mechanism of protective effects of EGCg against paraquat toxicity. , 2003, Toxicology.
[60] Tianhong Pan,et al. Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. , 2003, Life sciences.
[61] B. Frei,et al. Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.
[62] C. Rice-Evans,et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. , 2002, Free radical biology & medicine.
[63] Xudong Huang,et al. An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript* , 2002, The Journal of Biological Chemistry.
[64] Elizabeth C. Theil,et al. Multiple, Conserved Iron-responsive Elements in the 3′-Untranslated Region of Transferrin Receptor mRNA Enhance Binding of Iron Regulatory Protein 2* , 2002, The Journal of Biological Chemistry.
[65] C. Rice-Evans,et al. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide , 2002, Neurobiology of Aging.
[66] A. Kong,et al. Antioxidants and oxidants regulated signal transduction pathways. , 2002, Biochemical pharmacology.
[67] Yona Levites,et al. Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (−)-Epigallocatechin 3-Gallate Neuroprotective Action* , 2002, The Journal of Biological Chemistry.
[68] J H Weisburger,et al. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[69] Christine D Wu,et al. Tea as a functional food for oral health. , 2002, Nutrition.
[70] Harvey Checkoway,et al. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. , 2002, American journal of epidemiology.
[71] S. Suh,et al. The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons , 2001 .
[72] C. Rice-Evans,et al. Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. , 2001, Antioxidants & redox signaling.
[73] S. Mandel,et al. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration , 2001, Journal of neurochemistry.
[74] K. Senior. New genes reveal major role for iron in neurodegeneration , 2001, The Lancet.
[75] P. Maher. How Protein Kinase C Activation Protects Nerve Cells from Oxidative Stress-Induced Cell Death , 2001, The Journal of Neuroscience.
[76] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[77] S. Mandel,et al. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss. , 2001 .
[78] M Gallorini,et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes , 2001, Journal of neurochemistry.
[79] Y. Sagara,et al. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.
[80] P A Insel,et al. Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[81] F. Kusu,et al. Determination of catechins in human urine subsequent to tea ingestion by high-performance liquid chromatography with electrochemical detection. , 2000, Analytical biochemistry.
[82] Yasuyoshi Watanabe,et al. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons , 2000, Neuroscience Letters.
[83] David R Kaplan,et al. Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.
[84] C. Ho,et al. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. , 2000, Chemical research in toxicology.
[85] Jen-kun Lin,et al. Suppression of lipopolysaccharide-induced nuclear factor-κB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IκB kinase activity in macrophages , 2000 .
[86] M. Youdim,et al. The Future of Neuroprotection , 1999, Annals of the New York Academy of Sciences.
[87] G. Semenza,et al. Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.
[88] F. Nanjo,et al. Radical scavenging activity of tea catechins and their related compounds. , 1999, Bioscience, biotechnology, and biochemistry.
[89] S. Mandel,et al. Apomorphine protects against MPTP‐induced neurotoxicity in mice , 1999, Movement disorders : official journal of the Movement Disorder Society.
[90] Y. Kan,et al. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. , 1999, Bioscience, biotechnology, and biochemistry.
[91] D. Dorsa,et al. The Mitogen-Activated Protein Kinase Pathway Mediates Estrogen Neuroprotection after Glutamate Toxicity in Primary Cortical Neurons , 1999, The Journal of Neuroscience.
[92] E. Feskens,et al. Tea flavonols in cardiovascular disease and cancer epidemiology. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[93] G. Yang,et al. Inhibition of carcinogenesis by tea: bioavailability of tea polyphenols and mechanisms of actions. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[94] J. Hou,et al. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. , 1999, Biochimica et biophysica acta.
[95] Y. L. Lin,et al. Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages. , 1999, European journal of pharmacology.
[96] E. Hanson,et al. Hypoxia Post-translationally Activates Iron-regulatory Protein 2* , 1999, The Journal of Biological Chemistry.
[97] L. Hwang,et al. The antioxidative property of green tea against iron-induced oxidative stress in rat brain. , 1998, The Chinese journal of physiology.
[98] Fajun Yang,et al. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. , 1998, The Journal of nutrition.
[99] Hideyuki Ito,et al. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. , 1998, Carcinogenesis.
[100] W. May,et al. A Functional Role for Mitochondrial Protein Kinase Cα in Bcl2 Phosphorylation and Suppression of Apoptosis* , 1998, The Journal of Biological Chemistry.
[101] M. Youdim,et al. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐Hydroxydopamine , 1998, Movement disorders : official journal of the Movement Disorder Society.
[102] Z. Szallasi,et al. Overexpression of Protein Kinase C Isoform but not δ in Human Interleukin-3–Dependent Cells Suppresses Apoptosis and Induces bcl-2 Expression , 1998 .
[103] G. Binetti,et al. Specific role for protein kinase Cα in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts , 1998, Neuroscience Letters.
[104] S. Wiseman,et al. Antioxidants in tea. , 1997, Critical reviews in food science and nutrition.
[105] M. Chevion,et al. Protective effects of tea polyphenols against oxidative damage to red blood cells. , 1997, Biochemical pharmacology.
[106] Jen-kun Lin,et al. (−)-Epigallocatechin-3-gallate Blocks the Induction of Nitric Oxide Synthase by Down-Regulating Lipopolysaccharide-Induced Activity of Transcription Factor Nuclear Factor-κB , 1997 .
[107] Y Agid,et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[108] Richard Mayeux,et al. Diet and Parkinson's disease , 1997, Neurology.
[109] K. Nakagawa,et al. Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma. , 1997, Analytical biochemistry.
[110] C. Rice-Evans,et al. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. , 1997, Biochemical and biophysical research communications.
[111] Q. Guo,et al. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. , 1996, Biochimica et biophysica acta.
[112] B. Halliwell. Vitamin C: antioxidant or pro-oxidant in vivo? , 1996, Free radical research.
[113] S. Sakaguchi,et al. The Enhancing Effect of Tumour Necrosis Factor‐α on Oxidative Stress in Endotoxemia , 1996 .
[114] A. Seidler,et al. Diet and Parkinson's disease I , 1996, Neurology.
[115] T. Taniguchi,et al. Ca2+‐Dependent and Ca2+‐Independent Protein Kinase C Changes in the Brains of Patients with Alzheimer's Disease , 1996, Journal of neurochemistry.
[116] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[117] C. Rice-Evans,et al. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. , 1995, Archives of biochemistry and biophysics.
[118] R. Busto,et al. Regional Alterations of Protein Kinase C Activity Following Transient Cerebral Ischemia: Effects of Intraischemic Brain Temperature Modulation , 1994, Journal of neurochemistry.
[119] Minoru Harada,et al. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients , 1994, Neuroscience Letters.
[120] F. Watt,et al. Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis , 1994, Journal of neurochemistry.
[121] R. Wurtman,et al. Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase C alpha. , 1993, The Journal of biological chemistry.
[122] T. Wieloch,et al. Time Course of the Translocation and Inhibition of Protein kinase C During Complete Cerebral Ischemia in the Rat , 1993, Journal of neurochemistry.
[123] G. Lescoat,et al. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. , 1993, Biochemical pharmacology.
[124] Barry Halliwell,et al. Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.
[125] H N Graham,et al. Green tea composition, consumption, and polyphenol chemistry. , 1992, Preventive medicine.
[126] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[127] P Riederer,et al. Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.
[128] K. Jellinger,et al. The implications of increased iron in parkinsonian substantia nigra and its high affinity binding to melanin for dopamine neuron degeneration , 1990 .
[129] C. Winterbourn,et al. 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. , 1989, Biochemical pharmacology.
[130] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[131] M. Thompson,et al. Stability of flavonoid complexes of copper(II) and flavonoid antioxidant activity. , 1976, Analytica chimica acta.
[132] S. Mandel,et al. Multifunctional neuroprotective derivatives of rasagiline as anti-alzheimer’s disease drugs , 2011, Neurotherapeutics.
[133] Dongsun Park,et al. Green tea extract increases cyclophosphamide-induced teratogenesis by modulating the expression of cytochrome P-450 mRNA. , 2009, Reproductive toxicology.
[134] S. Mandel,et al. Green tea polyphenol (−)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal , 2009, Neurotoxicity Research.
[135] K. Choy,et al. Uptake and distribution of catechins in fetal organs following in utero exposure in rats. , 2007, Human reproduction.
[136] M. Youdim,et al. Iron and α-synuclein in the substantia nigra of MPTP-treated mice , 2007, Journal of Molecular Neuroscience.
[137] S. Mandel,et al. Green tea catechins as brain-permeable, non toxic iron chelators to "iron out iron" from the brain. , 2006, Journal of neural transmission. Supplementum.
[138] Xudong Tang,et al. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. , 2006, Molecular cancer therapeutics.
[139] B. Stockwell,et al. Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.
[140] Rusha Thomas,et al. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells. , 2005, Biochemical and biophysical research communications.
[141] J. Satoh,et al. The 14-3-3 Protein (cid:1) Isoform Expressed in Reactive Astrocytes in Demyelinating Lesions of Multiple Sclerosis Binds to Vimentin and Glial Fibrillary Acidic Protein in Cultured Human Astrocytes , 2004 .
[142] Chi-Tang Ho,et al. Green tea polyphenols , 2004 .
[143] S. Mandel,et al. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. , 2004, Journal of molecular neuroscience : MN.
[144] S. Mandel,et al. Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway. , 2003, Neurotoxicity research.
[145] D. Deleu,et al. Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson’s Disease , 2002, Clinical pharmacokinetics.
[146] S. Mandel,et al. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. , 2002, Biochemical pharmacology.
[147] Q. Guo,et al. Free radical scavenging by green tea polyphenols. , 2001, Methods in enzymology.
[148] R. Yu,et al. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death , 2000, Archives of pharmacal research.
[149] S. Lin-Shiau,et al. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. , 2000, Biochemical pharmacology.
[150] N. Cairns,et al. Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome. , 1999, Journal of neural transmission. Supplementum.
[151] E. Leibold,et al. Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species. , 1999, Gene expression.
[152] C. Gardana,et al. Catechin metabolites after intake of green tea infusions , 1998, BioFactors.
[153] Z. Szallasi,et al. Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. , 1998, Blood.
[154] Y. L. Lin,et al. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. , 1997, Molecular pharmacology.
[155] F. Nanjo,et al. Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. , 1996, Free radical biology & medicine.
[156] S A van Acker,et al. Structural aspects of antioxidant activity of flavonoids. , 1996, Free radical biology & medicine.
[157] S. Sakaguchi,et al. The enhancing effect of tumour necrosis factor-alpha on oxidative stress in endotoxemia. , 1996, Pharmacology & toxicology.
[158] P. Riederer,et al. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. , 1994, Neuroscience letters.
[159] P. Riederer,et al. Oxidative stress: free radical production in neural degeneration. , 1994, Pharmacology & therapeutics.
[160] P. Riederer,et al. Oxidative stress: a role in the pathogenesis of Parkinson's disease. , 1990, Journal of neural transmission. Supplementum.
[161] K. Jellinger,et al. Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.